nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—Chlorphenesin—CYP19A1—osteoporosis	0.00234	1	CrCbGaD
Esmolol—Paraesthesia—Ibandronate—osteoporosis	0.00174	0.00174	CcSEcCtD
Esmolol—Constipation—Estropipate—osteoporosis	0.00172	0.00173	CcSEcCtD
Esmolol—Pain—Estropipate—osteoporosis	0.00172	0.00173	CcSEcCtD
Esmolol—Dyspepsia—Raloxifene—osteoporosis	0.00172	0.00172	CcSEcCtD
Esmolol—Loss of consciousness—Risedronate—osteoporosis	0.00172	0.00172	CcSEcCtD
Esmolol—Mental disorder—Zoledronate—osteoporosis	0.00171	0.00171	CcSEcCtD
Esmolol—Agitation—Pamidronate—osteoporosis	0.00171	0.00171	CcSEcCtD
Esmolol—Dyspepsia—Ibandronate—osteoporosis	0.0017	0.00171	CcSEcCtD
Esmolol—Angiopathy—Conjugated Estrogens—osteoporosis	0.0017	0.00171	CcSEcCtD
Esmolol—Anxiety—Ethinyl Estradiol—osteoporosis	0.0017	0.0017	CcSEcCtD
Esmolol—Constipation—Alendronate—osteoporosis	0.0017	0.0017	CcSEcCtD
Esmolol—Pain—Alendronate—osteoporosis	0.0017	0.0017	CcSEcCtD
Esmolol—Angioedema—Pamidronate—osteoporosis	0.0017	0.0017	CcSEcCtD
Esmolol—Erythema—Zoledronate—osteoporosis	0.0017	0.0017	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.00169	0.0017	CcSEcCtD
Esmolol—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00169	0.00169	CcSEcCtD
Esmolol—Somnolence—Calcitriol—osteoporosis	0.00168	0.00169	CcSEcCtD
Esmolol—Decreased appetite—Ibandronate—osteoporosis	0.00168	0.00168	CcSEcCtD
Esmolol—Pain—Raloxifene—osteoporosis	0.00167	0.00167	CcSEcCtD
Esmolol—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00167	0.00167	CcSEcCtD
Esmolol—Fatigue—Ibandronate—osteoporosis	0.00167	0.00167	CcSEcCtD
Esmolol—Syncope—Pamidronate—osteoporosis	0.00166	0.00167	CcSEcCtD
Esmolol—Chest pain—Risedronate—osteoporosis	0.00166	0.00167	CcSEcCtD
Esmolol—Dysgeusia—Zoledronate—osteoporosis	0.00166	0.00166	CcSEcCtD
Esmolol—Anxiety—Risedronate—osteoporosis	0.00166	0.00166	CcSEcCtD
Esmolol—Constipation—Ibandronate—osteoporosis	0.00165	0.00166	CcSEcCtD
Esmolol—Pain—Ibandronate—osteoporosis	0.00165	0.00166	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00165	0.00165	CcSEcCtD
Esmolol—Pruritus—Etidronic acid—osteoporosis	0.00165	0.00165	CcSEcCtD
Esmolol—Acute coronary syndrome—Estradiol—osteoporosis	0.00165	0.00165	CcSEcCtD
Esmolol—Decreased appetite—Calcitriol—osteoporosis	0.00165	0.00165	CcSEcCtD
Esmolol—Mental disorder—Conjugated Estrogens—osteoporosis	0.00164	0.00165	CcSEcCtD
Esmolol—Neuropathy peripheral—Estradiol—osteoporosis	0.00164	0.00164	CcSEcCtD
Esmolol—Myocardial infarction—Estradiol—osteoporosis	0.00164	0.00164	CcSEcCtD
Esmolol—Feeling abnormal—Alendronate—osteoporosis	0.00164	0.00164	CcSEcCtD
Esmolol—Oedema—Ethinyl Estradiol—osteoporosis	0.00163	0.00164	CcSEcCtD
Esmolol—Erythema—Conjugated Estrogens—osteoporosis	0.00163	0.00164	CcSEcCtD
Esmolol—Loss of consciousness—Pamidronate—osteoporosis	0.00163	0.00164	CcSEcCtD
Esmolol—Dry mouth—Risedronate—osteoporosis	0.00163	0.00163	CcSEcCtD
Esmolol—Constipation—Calcitriol—osteoporosis	0.00162	0.00162	CcSEcCtD
Esmolol—Pain—Calcitriol—osteoporosis	0.00162	0.00162	CcSEcCtD
Esmolol—Convulsion—Pamidronate—osteoporosis	0.00161	0.00161	CcSEcCtD
Esmolol—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.0016	0.00161	CcSEcCtD
Esmolol—Urticaria—Estropipate—osteoporosis	0.0016	0.00161	CcSEcCtD
Esmolol—Dysgeusia—Conjugated Estrogens—osteoporosis	0.0016	0.0016	CcSEcCtD
Esmolol—Body temperature increased—Estropipate—osteoporosis	0.00159	0.0016	CcSEcCtD
Esmolol—Feeling abnormal—Ibandronate—osteoporosis	0.00159	0.0016	CcSEcCtD
Esmolol—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00159	0.00159	CcSEcCtD
Esmolol—Urticaria—Alendronate—osteoporosis	0.00158	0.00158	CcSEcCtD
Esmolol—Anxiety—Pamidronate—osteoporosis	0.00157	0.00158	CcSEcCtD
Esmolol—Body temperature increased—Alendronate—osteoporosis	0.00157	0.00157	CcSEcCtD
Esmolol—Shock—Risedronate—osteoporosis	0.00157	0.00157	CcSEcCtD
Esmolol—Nervous system disorder—Risedronate—osteoporosis	0.00156	0.00157	CcSEcCtD
Esmolol—Agitation—Zoledronate—osteoporosis	0.00156	0.00156	CcSEcCtD
Esmolol—Angioedema—Zoledronate—osteoporosis	0.00155	0.00155	CcSEcCtD
Esmolol—Skin disorder—Risedronate—osteoporosis	0.00155	0.00155	CcSEcCtD
Esmolol—Body temperature increased—Raloxifene—osteoporosis	0.00154	0.00155	CcSEcCtD
Esmolol—Urticaria—Ibandronate—osteoporosis	0.00154	0.00154	CcSEcCtD
Esmolol—Body temperature increased—Ibandronate—osteoporosis	0.00153	0.00153	CcSEcCtD
Esmolol—Confusional state—Pamidronate—osteoporosis	0.00153	0.00153	CcSEcCtD
Esmolol—Syncope—Zoledronate—osteoporosis	0.00152	0.00152	CcSEcCtD
Esmolol—Oedema—Pamidronate—osteoporosis	0.00151	0.00152	CcSEcCtD
Esmolol—Rhinitis—Estradiol—osteoporosis	0.0015	0.00151	CcSEcCtD
Esmolol—Urticaria—Calcitriol—osteoporosis	0.0015	0.00151	CcSEcCtD
Esmolol—Body temperature increased—Calcitriol—osteoporosis	0.0015	0.0015	CcSEcCtD
Esmolol—Angioedema—Conjugated Estrogens—osteoporosis	0.00149	0.0015	CcSEcCtD
Esmolol—Shock—Pamidronate—osteoporosis	0.00149	0.00149	CcSEcCtD
Esmolol—Loss of consciousness—Zoledronate—osteoporosis	0.00149	0.00149	CcSEcCtD
Esmolol—Pharyngitis—Estradiol—osteoporosis	0.00149	0.00149	CcSEcCtD
Esmolol—Nervous system disorder—Pamidronate—osteoporosis	0.00149	0.00149	CcSEcCtD
Esmolol—Urinary tract disorder—Estradiol—osteoporosis	0.00148	0.00149	CcSEcCtD
Esmolol—Vomiting—Etidronic acid—osteoporosis	0.00148	0.00149	CcSEcCtD
Esmolol—Urethral disorder—Estradiol—osteoporosis	0.00147	0.00147	CcSEcCtD
Esmolol—Convulsion—Zoledronate—osteoporosis	0.00147	0.00147	CcSEcCtD
Esmolol—Hyperhidrosis—Pamidronate—osteoporosis	0.00146	0.00147	CcSEcCtD
Esmolol—Syncope—Conjugated Estrogens—osteoporosis	0.00146	0.00147	CcSEcCtD
Esmolol—Headache—Etidronic acid—osteoporosis	0.00146	0.00146	CcSEcCtD
Esmolol—Asthenia—Estropipate—osteoporosis	0.00145	0.00145	CcSEcCtD
Esmolol—Visual impairment—Estradiol—osteoporosis	0.00145	0.00145	CcSEcCtD
Esmolol—Anorexia—Pamidronate—osteoporosis	0.00144	0.00145	CcSEcCtD
Esmolol—Chest pain—Zoledronate—osteoporosis	0.00144	0.00145	CcSEcCtD
Esmolol—Anxiety—Zoledronate—osteoporosis	0.00144	0.00144	CcSEcCtD
Esmolol—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00143	0.00144	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00143	0.00144	CcSEcCtD
Esmolol—Paraesthesia—Risedronate—osteoporosis	0.00143	0.00143	CcSEcCtD
Esmolol—Pruritus—Estropipate—osteoporosis	0.00143	0.00143	CcSEcCtD
Esmolol—Asthenia—Alendronate—osteoporosis	0.00142	0.00143	CcSEcCtD
Esmolol—Dyspnoea—Risedronate—osteoporosis	0.00142	0.00142	CcSEcCtD
Esmolol—Hypotension—Pamidronate—osteoporosis	0.00142	0.00142	CcSEcCtD
Esmolol—Convulsion—Conjugated Estrogens—osteoporosis	0.00141	0.00142	CcSEcCtD
Esmolol—Dry mouth—Zoledronate—osteoporosis	0.00141	0.00142	CcSEcCtD
Esmolol—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00141	0.00141	CcSEcCtD
Esmolol—Fatigue—Ethinyl Estradiol—osteoporosis	0.00141	0.00141	CcSEcCtD
Esmolol—Pruritus—Alendronate—osteoporosis	0.00141	0.00141	CcSEcCtD
Esmolol—Dyspepsia—Risedronate—osteoporosis	0.0014	0.00141	CcSEcCtD
Esmolol—Constipation—Ethinyl Estradiol—osteoporosis	0.0014	0.0014	CcSEcCtD
Esmolol—Confusional state—Zoledronate—osteoporosis	0.0014	0.0014	CcSEcCtD
Esmolol—Flushing—Estradiol—osteoporosis	0.00139	0.0014	CcSEcCtD
Esmolol—Cardiac disorder—Estradiol—osteoporosis	0.00139	0.0014	CcSEcCtD
Esmolol—Chest pain—Conjugated Estrogens—osteoporosis	0.00139	0.00139	CcSEcCtD
Esmolol—Asthenia—Ibandronate—osteoporosis	0.00139	0.00139	CcSEcCtD
Esmolol—Anxiety—Conjugated Estrogens—osteoporosis	0.00139	0.00139	CcSEcCtD
Esmolol—Nausea—Etidronic acid—osteoporosis	0.00138	0.00139	CcSEcCtD
Esmolol—Oedema—Zoledronate—osteoporosis	0.00138	0.00139	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00138	0.00138	CcSEcCtD
Esmolol—Gastrointestinal disorder—Risedronate—osteoporosis	0.00138	0.00138	CcSEcCtD
Esmolol—Fatigue—Risedronate—osteoporosis	0.00137	0.00138	CcSEcCtD
Esmolol—Pruritus—Ibandronate—osteoporosis	0.00137	0.00137	CcSEcCtD
Esmolol—Pain—Risedronate—osteoporosis	0.00136	0.00137	CcSEcCtD
Esmolol—Constipation—Risedronate—osteoporosis	0.00136	0.00137	CcSEcCtD
Esmolol—Angiopathy—Estradiol—osteoporosis	0.00136	0.00136	CcSEcCtD
Esmolol—Shock—Zoledronate—osteoporosis	0.00136	0.00136	CcSEcCtD
Esmolol—Paraesthesia—Pamidronate—osteoporosis	0.00136	0.00136	CcSEcCtD
Esmolol—Asthenia—Calcitriol—osteoporosis	0.00136	0.00136	CcSEcCtD
Esmolol—Nervous system disorder—Zoledronate—osteoporosis	0.00136	0.00136	CcSEcCtD
Esmolol—Dyspnoea—Pamidronate—osteoporosis	0.00135	0.00135	CcSEcCtD
Esmolol—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00135	0.00135	CcSEcCtD
Esmolol—Chills—Estradiol—osteoporosis	0.00135	0.00135	CcSEcCtD
Esmolol—Somnolence—Pamidronate—osteoporosis	0.00135	0.00135	CcSEcCtD
Esmolol—Skin disorder—Zoledronate—osteoporosis	0.00134	0.00135	CcSEcCtD
Esmolol—Pruritus—Calcitriol—osteoporosis	0.00134	0.00134	CcSEcCtD
Esmolol—Hyperhidrosis—Zoledronate—osteoporosis	0.00134	0.00134	CcSEcCtD
Esmolol—Dyspepsia—Pamidronate—osteoporosis	0.00133	0.00134	CcSEcCtD
Esmolol—Dizziness—Estropipate—osteoporosis	0.00133	0.00134	CcSEcCtD
Esmolol—Oedema—Conjugated Estrogens—osteoporosis	0.00133	0.00134	CcSEcCtD
Esmolol—Anorexia—Zoledronate—osteoporosis	0.00132	0.00132	CcSEcCtD
Esmolol—Decreased appetite—Pamidronate—osteoporosis	0.00132	0.00132	CcSEcCtD
Esmolol—Mental disorder—Estradiol—osteoporosis	0.00131	0.00132	CcSEcCtD
Esmolol—Dizziness—Alendronate—osteoporosis	0.00131	0.00132	CcSEcCtD
Esmolol—Shock—Conjugated Estrogens—osteoporosis	0.00131	0.00131	CcSEcCtD
Esmolol—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00131	0.00131	CcSEcCtD
Esmolol—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00131	0.00131	CcSEcCtD
Esmolol—Erythema—Estradiol—osteoporosis	0.00131	0.00131	CcSEcCtD
Esmolol—Fatigue—Pamidronate—osteoporosis	0.00131	0.00131	CcSEcCtD
Esmolol—Urticaria—Ethinyl Estradiol—osteoporosis	0.0013	0.0013	CcSEcCtD
Esmolol—Pain—Pamidronate—osteoporosis	0.0013	0.0013	CcSEcCtD
Esmolol—Constipation—Pamidronate—osteoporosis	0.0013	0.0013	CcSEcCtD
Esmolol—Skin disorder—Conjugated Estrogens—osteoporosis	0.00129	0.0013	CcSEcCtD
Esmolol—Hypotension—Zoledronate—osteoporosis	0.00129	0.0013	CcSEcCtD
Esmolol—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00129	0.0013	CcSEcCtD
Esmolol—Dizziness—Raloxifene—osteoporosis	0.00129	0.00129	CcSEcCtD
Esmolol—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00129	0.00129	CcSEcCtD
Esmolol—Vomiting—Estropipate—osteoporosis	0.00128	0.00129	CcSEcCtD
Esmolol—Dysgeusia—Estradiol—osteoporosis	0.00128	0.00128	CcSEcCtD
Esmolol—Dizziness—Ibandronate—osteoporosis	0.00128	0.00128	CcSEcCtD
Esmolol—Anorexia—Conjugated Estrogens—osteoporosis	0.00127	0.00127	CcSEcCtD
Esmolol—Urticaria—Risedronate—osteoporosis	0.00127	0.00127	CcSEcCtD
Esmolol—Headache—Estropipate—osteoporosis	0.00126	0.00127	CcSEcCtD
Esmolol—Vomiting—Alendronate—osteoporosis	0.00126	0.00127	CcSEcCtD
Esmolol—Body temperature increased—Risedronate—osteoporosis	0.00126	0.00126	CcSEcCtD
Esmolol—Feeling abnormal—Pamidronate—osteoporosis	0.00125	0.00125	CcSEcCtD
Esmolol—Hypotension—Conjugated Estrogens—osteoporosis	0.00125	0.00125	CcSEcCtD
Esmolol—Headache—Alendronate—osteoporosis	0.00124	0.00125	CcSEcCtD
Esmolol—Paraesthesia—Zoledronate—osteoporosis	0.00124	0.00125	CcSEcCtD
Esmolol—Vomiting—Raloxifene—osteoporosis	0.00124	0.00124	CcSEcCtD
Esmolol—Dyspnoea—Zoledronate—osteoporosis	0.00123	0.00124	CcSEcCtD
Esmolol—Somnolence—Zoledronate—osteoporosis	0.00123	0.00123	CcSEcCtD
Esmolol—Vomiting—Ibandronate—osteoporosis	0.00123	0.00123	CcSEcCtD
Esmolol—Headache—Raloxifene—osteoporosis	0.00122	0.00123	CcSEcCtD
Esmolol—Dyspepsia—Zoledronate—osteoporosis	0.00122	0.00122	CcSEcCtD
Esmolol—Headache—Ibandronate—osteoporosis	0.00121	0.00121	CcSEcCtD
Esmolol—Vomiting—Calcitriol—osteoporosis	0.0012	0.00121	CcSEcCtD
Esmolol—Decreased appetite—Zoledronate—osteoporosis	0.0012	0.00121	CcSEcCtD
Esmolol—Agitation—Estradiol—osteoporosis	0.0012	0.0012	CcSEcCtD
Esmolol—Nausea—Estropipate—osteoporosis	0.0012	0.0012	CcSEcCtD
Esmolol—Body temperature increased—Pamidronate—osteoporosis	0.0012	0.0012	CcSEcCtD
Esmolol—Paraesthesia—Conjugated Estrogens—osteoporosis	0.0012	0.0012	CcSEcCtD
Esmolol—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00119	0.0012	CcSEcCtD
Esmolol—Angioedema—Estradiol—osteoporosis	0.00119	0.0012	CcSEcCtD
Esmolol—Fatigue—Zoledronate—osteoporosis	0.00119	0.0012	CcSEcCtD
Esmolol—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00119	0.00119	CcSEcCtD
Esmolol—Headache—Calcitriol—osteoporosis	0.00119	0.00119	CcSEcCtD
Esmolol—Somnolence—Conjugated Estrogens—osteoporosis	0.00118	0.00119	CcSEcCtD
Esmolol—Pain—Zoledronate—osteoporosis	0.00118	0.00119	CcSEcCtD
Esmolol—Constipation—Zoledronate—osteoporosis	0.00118	0.00119	CcSEcCtD
Esmolol—Nausea—Alendronate—osteoporosis	0.00118	0.00118	CcSEcCtD
Esmolol—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00117	0.00118	CcSEcCtD
Esmolol—Asthenia—Ethinyl Estradiol—osteoporosis	0.00117	0.00118	CcSEcCtD
Esmolol—Syncope—Estradiol—osteoporosis	0.00117	0.00117	CcSEcCtD
Esmolol—Nausea—Raloxifene—osteoporosis	0.00116	0.00116	CcSEcCtD
Esmolol—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00116	0.00116	CcSEcCtD
Esmolol—Pruritus—Ethinyl Estradiol—osteoporosis	0.00116	0.00116	CcSEcCtD
Esmolol—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00115	0.00115	CcSEcCtD
Esmolol—Fatigue—Conjugated Estrogens—osteoporosis	0.00115	0.00115	CcSEcCtD
Esmolol—Nausea—Ibandronate—osteoporosis	0.00115	0.00115	CcSEcCtD
Esmolol—Loss of consciousness—Estradiol—osteoporosis	0.00115	0.00115	CcSEcCtD
Esmolol—Asthenia—Risedronate—osteoporosis	0.00114	0.00115	CcSEcCtD
Esmolol—Feeling abnormal—Zoledronate—osteoporosis	0.00114	0.00114	CcSEcCtD
Esmolol—Constipation—Conjugated Estrogens—osteoporosis	0.00114	0.00114	CcSEcCtD
Esmolol—Pain—Conjugated Estrogens—osteoporosis	0.00114	0.00114	CcSEcCtD
Esmolol—Pruritus—Risedronate—osteoporosis	0.00113	0.00113	CcSEcCtD
Esmolol—Nausea—Calcitriol—osteoporosis	0.00112	0.00113	CcSEcCtD
Esmolol—Chest pain—Estradiol—osteoporosis	0.00111	0.00112	CcSEcCtD
Esmolol—Anxiety—Estradiol—osteoporosis	0.00111	0.00111	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.0011	0.00111	CcSEcCtD
Esmolol—Urticaria—Zoledronate—osteoporosis	0.0011	0.0011	CcSEcCtD
Esmolol—Body temperature increased—Zoledronate—osteoporosis	0.00109	0.0011	CcSEcCtD
Esmolol—Dry mouth—Estradiol—osteoporosis	0.00109	0.00109	CcSEcCtD
Esmolol—Asthenia—Pamidronate—osteoporosis	0.00109	0.00109	CcSEcCtD
Esmolol—Dizziness—Ethinyl Estradiol—osteoporosis	0.00108	0.00108	CcSEcCtD
Esmolol—Confusional state—Estradiol—osteoporosis	0.00108	0.00108	CcSEcCtD
Esmolol—Pruritus—Pamidronate—osteoporosis	0.00107	0.00107	CcSEcCtD
Esmolol—Oedema—Estradiol—osteoporosis	0.00107	0.00107	CcSEcCtD
Esmolol—Urticaria—Conjugated Estrogens—osteoporosis	0.00106	0.00106	CcSEcCtD
Esmolol—Dizziness—Risedronate—osteoporosis	0.00105	0.00106	CcSEcCtD
Esmolol—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00105	0.00106	CcSEcCtD
Esmolol—Shock—Estradiol—osteoporosis	0.00105	0.00105	CcSEcCtD
Esmolol—Nervous system disorder—Estradiol—osteoporosis	0.00105	0.00105	CcSEcCtD
Esmolol—Vomiting—Ethinyl Estradiol—osteoporosis	0.00104	0.00104	CcSEcCtD
Esmolol—Skin disorder—Estradiol—osteoporosis	0.00104	0.00104	CcSEcCtD
Esmolol—Hyperhidrosis—Estradiol—osteoporosis	0.00103	0.00103	CcSEcCtD
Esmolol—Headache—Ethinyl Estradiol—osteoporosis	0.00102	0.00103	CcSEcCtD
Esmolol—Vomiting—Risedronate—osteoporosis	0.00101	0.00102	CcSEcCtD
Esmolol—Dizziness—Pamidronate—osteoporosis	0.001	0.001	CcSEcCtD
Esmolol—Headache—Risedronate—osteoporosis	0.000998	0.001	CcSEcCtD
Esmolol—Asthenia—Zoledronate—osteoporosis	0.000993	0.000995	CcSEcCtD
Esmolol—Pruritus—Zoledronate—osteoporosis	0.000979	0.000981	CcSEcCtD
Esmolol—Nausea—Ethinyl Estradiol—osteoporosis	0.000971	0.000973	CcSEcCtD
Esmolol—Vomiting—Pamidronate—osteoporosis	0.000963	0.000965	CcSEcCtD
Esmolol—Paraesthesia—Estradiol—osteoporosis	0.000958	0.00096	CcSEcCtD
Esmolol—Asthenia—Conjugated Estrogens—osteoporosis	0.000956	0.000958	CcSEcCtD
Esmolol—Dyspnoea—Estradiol—osteoporosis	0.000951	0.000953	CcSEcCtD
Esmolol—Headache—Pamidronate—osteoporosis	0.000949	0.000951	CcSEcCtD
Esmolol—Somnolence—Estradiol—osteoporosis	0.000948	0.00095	CcSEcCtD
Esmolol—Nausea—Risedronate—osteoporosis	0.000947	0.000949	CcSEcCtD
Esmolol—Pruritus—Conjugated Estrogens—osteoporosis	0.000943	0.000945	CcSEcCtD
Esmolol—Dyspepsia—Estradiol—osteoporosis	0.000939	0.000941	CcSEcCtD
Esmolol—Decreased appetite—Estradiol—osteoporosis	0.000927	0.000929	CcSEcCtD
Esmolol—Gastrointestinal disorder—Estradiol—osteoporosis	0.000921	0.000923	CcSEcCtD
Esmolol—Fatigue—Estradiol—osteoporosis	0.000919	0.000922	CcSEcCtD
Esmolol—Dizziness—Zoledronate—osteoporosis	0.000915	0.000917	CcSEcCtD
Esmolol—Pain—Estradiol—osteoporosis	0.000912	0.000914	CcSEcCtD
Esmolol—Constipation—Estradiol—osteoporosis	0.000912	0.000914	CcSEcCtD
Esmolol—Nausea—Pamidronate—osteoporosis	0.0009	0.000902	CcSEcCtD
Esmolol—Dizziness—Conjugated Estrogens—osteoporosis	0.000881	0.000883	CcSEcCtD
Esmolol—Vomiting—Zoledronate—osteoporosis	0.00088	0.000882	CcSEcCtD
Esmolol—Feeling abnormal—Estradiol—osteoporosis	0.000879	0.000881	CcSEcCtD
Esmolol—Headache—Zoledronate—osteoporosis	0.000867	0.000869	CcSEcCtD
Esmolol—Vomiting—Conjugated Estrogens—osteoporosis	0.000847	0.000849	CcSEcCtD
Esmolol—Urticaria—Estradiol—osteoporosis	0.000847	0.000849	CcSEcCtD
Esmolol—Body temperature increased—Estradiol—osteoporosis	0.000843	0.000845	CcSEcCtD
Esmolol—Headache—Conjugated Estrogens—osteoporosis	0.000835	0.000837	CcSEcCtD
Esmolol—Nausea—Zoledronate—osteoporosis	0.000822	0.000824	CcSEcCtD
Esmolol—Nausea—Conjugated Estrogens—osteoporosis	0.000791	0.000793	CcSEcCtD
Esmolol—Asthenia—Estradiol—osteoporosis	0.000765	0.000767	CcSEcCtD
Esmolol—Pruritus—Estradiol—osteoporosis	0.000754	0.000756	CcSEcCtD
Esmolol—Dizziness—Estradiol—osteoporosis	0.000705	0.000707	CcSEcCtD
Esmolol—Vomiting—Estradiol—osteoporosis	0.000678	0.00068	CcSEcCtD
Esmolol—Headache—Estradiol—osteoporosis	0.000668	0.00067	CcSEcCtD
Esmolol—Nausea—Estradiol—osteoporosis	0.000633	0.000635	CcSEcCtD
